Background: A pharmaco-chemical investigation of the Euphorbia cyparissias plant was justified by its known multiple therapeutic valences. Numerous components from extracts and latex of Euphorbiacae were identified, revealing a large plant family with a polyvalent therapeutic activity.
Introduction
In modern human and veterinary therapeutics, the concept of biotherapy has become more frequent. In this context, researchers from all over the world are seeking to align, and to bring new information in relation to the use of plants from the spontaneous flora as well as other modern means in the anti-parasitic arsenal (Madzimure et Numerous components from extracts and latex of Euphorbiacee were identified, mostly diterpenes: phorbolester (ingenole), euphorbone, piceatanole, aesculetine, jolkinol, hyperoside, kaempferol, acylphorbol, acylingenol etc. (Ahmad and Jassbi, 1999; Evanics et al., 2001; Ferriera et al., 1993) . Pharmaco-chemical investigation of the Euphorbiaceae family is justified by its known multiple therapeutic valences (Özbilgin and Saltan Citoğlu, 2012; Tabuti, 2008) . Numbering over 3000, species, this large plant family is a polyvalent one from a medicinal point of view: with cancer studied efficiency (Wang et al., 2012) , homeopathic (Garcia et al., 2010) , anti-inflammatory (Singh et al., 1984) , insecticidal , repellent (Ogunlesi et al., 2009 ), antiviral (Akihisa et al., 2002) , diuretic (Ashok et al., 2011 ) and many others (Shih and Cherng, 2012) .
The aim was to assess the skin tolerance to irritation on different testing concentrations, of Euphorbia cyparissias extracts and ointments, in laboratory rats and dog, with the identification of all possible skin injuries and histological changes, registering, after a simple patch test methodology, as a preliminary step in conception of a final formulation, a specific ointment with E. cyparissias extract.
Materials and Methods

Euphorbia ointment and dilutions preparation
Euphorbia cyparissias was collected from Banat region, Western Romania (plant's identification and authentication was made; plant being compared with a herbarium specimen (voucher no. 41), from the collection of Vegetal Biology and Medicinal Plants Department from FVM Timisoara, Romania.
Plant extracts were obtained according to Romanian Pharmacopeia, X th Ed. (1993), instructions at Tincturae or Unguenta monographs. 100 ml E. cyparissias, 20% mother tincture previously obtained was evaporated and concentrated on marine bath. Over it, 50 g ointment base was added progressively, mixing continuously for 20 minutes, until total tincture's embedding in the ointment mass. After homogenisation the hot ointment was poured in plastic boxes, eliminating oxygen bubbles and left to stand for 60 minutes, so being obtained a prime 10% E. cyparissias ointment.
The used ointment base, Ultrabasic cream (Ratiopharm GmbH, Germany), was an amphiphylic complex basis adjusted to pH = 5, choosing of this ointment base being precisely recommended, due to its good incorporating features of the vegetal complex compositions, tannins, latex, oils etc. For this reason, this base was considered ideal for skin topical applications, being well tolerated and forming uniform films on skin. Hot 10% ointment was then successively diluted in the following proportions: 1:1 (w/w) to obtain concentration of 5%; 1: 2.5 (w/w) to a concentration of 2% and respectively; 1:1 (w/w) to concentration of 1%.
As initial testing before the patch test, the mother E. cyparissias tincture 20% concentration (considered by us as the maximum therapeutic concentration in animals) it was used only on rats, in the aim to see if there are any changes that may occur in cutis structure, Application of the E. cyparissias ointments was accomplished with protected hand, avoiding the contact with eyelid mucous.
Patch-test methodology
The test was performed accordingly to a simple patch test method protocols, accepted in dermatology, both for rats and dog. During testing, all major local and general side effects: the degree and nature of irritation, mother tincture and ointment's corrosivity, reversibility of installed damages and any other local or general toxic effect (Ale and Maibach, 2010; DermNet NZ, 2012; Spiewak, 2008). In Table 1 , animals used and methodology are presented. Skin reaction assessing was done after classical scoring by grades from 0 to 4, final quantification of sensitivity testing being based on average mark of the subjects included in the study (Table 2) . 
Histological investigation Skin samples
Samples were collected from rats euthanized in the respect of current standards of ethics in scientific research. Rats were euthanized in accordance with European Directive 2010/63/EU from 09/22/2010. Euthanasia method used was that by overdosing anesthetic agents using the association: Ketamine (Intervet, Boxmeere, The Netherlands) (300 mgkg -1 bw) and xylazine Narcoxyl 2 (Xylazine, MSD Animal Health, Boxmeere, The Netherlands) 30 mgkg -1 bw, i.e. 0.3 ml ketamine + 0.15 ml xylazine /100gkg Skin flaps from rats were placed in 5% formalin solution for histological processing (Șincai, 2000) . From dog the skin samples were collected surgically and places were sanitized and coated with protective sulphonamide powder, to avoid any local infections.
Staining method
The method used for rat skin was haematoxylin-eosin (col. H & E). For coloration of dog skin samples, trichromic Mallory staining was used (col. TRC), which contains acid fuchsine solution, phosphomolybdate acid solution and Mallory mix, being a specific staining for conjunctive tissue, nuclei and fibres (Șincai, 2000) , microscopy being performed to the Olympus CX 41(Olympus, GmbH Germany), equipped with a camera, to the objective x 200 (H&E), and of x 400 (col. TRC).
Results and Discussion
Tested ointment proved to be bearable on rats' epilated skin at concentrations of 1, 2, and / or 5% ( Table 3) . Contact of rats skin with high concentrations ointment (10%), led to reduced and short term irritation of the cutis and caused reactions includable in skin tolerance Class I = medium irritating. When mother tincture (20%) was used, detected changes were characteristic to category SI = strong irritant reactions, due to irritating action, situation also revealed by the histological examination (Figures 1 to 6 ). 
Histological
To concentrations inferior to 20%, were not identified significant histological changes. The main changes identified were: thickening of the epidermis, especially of the stratum corneum, keratinocytes vacuolar degeneration, small areas damage of lamina basalis, who separates the epidermis and papillary dermis and occurrence of cells specific to dermal inflammatory process (only at concentrations of 10% and especially to 20%) (Figures 1 to 6 ). Histological sections revealed that the epidermis has a normal appearance with multi-layered intact epithelium, where there are vacuolated keratinocytes but in reduced proportion (red). Skin thickness is maintained within normal limits. In the dermis were revealed very few inflammatory cells (orange). Also glandular structures (in particular, the sebaceous gland (blue) corneous formations (hair) do not show significant changes. Histologic examination of the skin did not highlighted major changes. Epidermis showed no structural changes or of thickness but compared with group 1% it was found an increased number of inflammatory type cells (red). fig. 3) and 10% (fig. 4 ) ointment concentrations (Col. H&E x 200). Histologic examination of the skin that was applied with 5 ( fig. 3) and 10% (fig. 4) ointment concentrations (col. H&E x 200) Histologic examination of the skin showed for both concentrations, but especially for the higher one, development of the contact dermatitis phenomena. Diskeratosis, hypo-or parakeratosis (orange) it was observed also altered membrana basalis and circumscribed cellular infiltrations in dermis were observed, as the occurrence of specific inflammatory process (red). Histologic examination of the skin showed worsening of contact dermatitis. In addition, most of the sebaceous glands necrosis in various stages from partial (red) to complete (black) of secretor and basal proliferative cells, which become flattened. Alveolar sacs are empty of cells and by its secretion product. These aspects indicate severe reduction in functional capacity of the sebaceous gland ( fig.5) . Thus, the sebum quantity secreted are greatly diminished, a phenomenon that explains the dry and brittle skin in case of concentrated ointments using. In the dermis massive cellular infiltration was observed, specific to inflammatory processes (red) (Figure.6 ).
Dermatological testing in dog
Evaluation of coetaneous tolerance for ointments was followed on a Cocker spaniel dog. Testing showed total non-irritant character of 1%, 2% ointment concentrations, not being identified any local or general reactions. In the case of 5% concentration, only light coetaneous reactions, reported tolerance values being includable in B = bearable category of acanthosis.
Histological
The main histological changes were observed in skin structure only after applying E. cyparissias ointment with concentration of 5% and there were: thickening of the epidermis, especially of stratum corneum, keratinocytes' vacuolar degeneration, destruction of small portions of lamina basalis, specific for the dermal inflammatory process (for 5% ointment). It is to note that at lower concentrations weren't identified any significant histological changes (Figures 7 and 8 ). Thickening of epidermis (orange); skin peeling (black); vacuolar degeneration of keratinocytes (blue); destruction of lamina basalis (red); cell proliferation in the dermis, specific to inflammatory process (green).
Dermatologic observations on human volunteer
Applications on arm' skin did not cause any irritation, discoloration or volume modification at any of the studied concentrations. In the case of palbebral topical applications, ointments were applied on eyelids as follows: right upper eyelid 1%, lower left eyelid 2% above 5%. After 3-8 hours after ointments application, subject felt a diffuse burning irritation only after applying ointment with concentration of 5%. Irritation was felt only to the correspondent lid (top left). After 8 hours after application, sore diminished, but the complete recovery after swelling of the eyelids was observed only at 24 hours after application. Edema was persistent yet after 48 hours of application, but it was not accompanied by pain or other event. Accordingly to our estimation methodology, recorded effects can be included in average affordability (1 to 2.79).
Studies made by our research team about the active compounds of Euphorbia cyparissias (Cypress spurge) as well as their activity in vivo and in vitro revealed additional significant ectoparasitic activity, especially against argasides and dog's demodectic mange (Cristina et al., 2008) . Present testing occurred due to the need to further studies of the above-mentioned compounds activity in demodicosis, a zoonotic skin parasitic disease frequent in dogs and enough spread in humans, where the ointment was originally used by us and where acanthosis studies are needed (Lachapelle and Maibach, 2012, EAHC, 2009; Spiewak, 2008) .
Conclusions
Euphorbia cyparissias ointment dermatologically tested on rats, proved to be bearable on epilated skin at concentrations of 1, 2 and 5%. Ointments and mother tincture with higher concentrations (10% and 20%) led to irritation and cutis damages, histologicaly revealed. Ointment tested on dog's cutis appears to be tolerable for epilated skin to concentrations of 1, 2 and/or 5%. However, to the contact with epilated skin of ointments with concentration of 5%, can register very small and short term irritation of the cutis, which can be considered therapeutically negligible, histological examination revealing this situation. Euphorbia cyparissias ointment can be used in veterinary therapy at the concentrations of 2 and 5% without encountering difficulty, ointments at this concentration being included in the bearable non-irritant category. Application of E. cyparissias ointments hould be made with protected hand, avoiding the contact with mucous eyelid.
